|
山東威高集團醫用高分子製品股份有限公司 - H股, 01066.HK - 綜合損益表 |
2021-12 |
2020-12 |
2019-12 |
2018-12 |
2017-12 |
2016-12 |
2015-12 |
2014-12 |
2013-12 |
2012-12 |
2011-12 |
2010-12 |
2009-12 |
2008-12 |
2007-12 |
2006-12 |
2005-12 |
營業額 |
13,151,719 |
11,622,337 |
10,383,885 |
8,808,861 |
6,292,641 |
5,619,842 |
5,918,930 |
5,277,827 |
4,613,310 |
3,689,115 |
3,180,577 |
2,462,557 |
1,878,495 |
1,514,367 |
1,095,109 |
786,926 |
569,987 |
經營溢利 |
2,771,733 |
2,556,288 |
2,171,273 |
1,741,969 |
1,524,265 |
1,186,675 |
1,332,369 |
1,280,543 |
1,047,061 |
953,293 |
981,811 |
843,744 |
704,960 |
524,082 |
332,074 |
156,886 |
104,560 |
非經營/ 特殊項目 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
聯營公司 |
69,988 |
9,171 |
81,097 |
33,246 |
0 |
0 |
601 |
-4,879 |
62,325 |
172,882 |
51,419 |
44,140 |
0 |
0 |
0 |
32,462 |
-1,980 |
除稅前經營溢利 |
2,841,721 |
2,565,459 |
2,252,370 |
1,775,215 |
1,525,611 |
1,186,675 |
1,335,505 |
1,275,664 |
544,154 |
1,126,175 |
3,592,506 |
887,884 |
704,960 |
524,082 |
332,074 |
189,348 |
102,580 |
稅項 |
415,093 |
358,422 |
327,137 |
258,431 |
224,399 |
153,836 |
186,647 |
180,844 |
156,475 |
129,805 |
124,472 |
85,532 |
71,782 |
38,977 |
2,732 |
6,745 |
2 |
少數股東權益 |
181,850 |
120,254 |
75,297 |
43,849 |
96,673 |
31,659 |
36,122 |
9,872 |
-305 |
-116 |
5,862 |
3,280 |
-686 |
2,711 |
21,193 |
11,682 |
1,378 |
股東應占溢利 |
2,244,778 |
2,086,783 |
1,849,936 |
1,472,935 |
1,728,660 |
1,105,933 |
1,112,736 |
1,084,948 |
387,984 |
996,486 |
3,462,172 |
799,072 |
633,864 |
482,394 |
308,149 |
170,921 |
101,200 |
貨幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
單位 |
千 |
千 |
千 |
千 |
千 |
千 |
千 |
主要項目 |
折舊 |
723,813 |
711,532 |
614,960 |
562,558 |
262,597 |
260,006 |
316,372 |
244,484 |
187,961 |
128,342 |
97,714 |
90,955 |
71,645 |
57,137 |
47,083 |
43,308 |
23,863 |
利息 |
140,396 |
178,935 |
397,948 |
284,408 |
23,889 |
25,065 |
47,519 |
28,658 |
16,275 |
5,031 |
4,438 |
10,722 |
7,131 |
35,560 |
21,905 |
21,519 |
17,038 |
利息撥作發展資本 |
0 |
0 |
0 |
0 |
0 |
0 |
3,022 |
5,953 |
7,318 |
353 |
3,296 |
1,064 |
3,128 |
4,904 |
4,040 |
0 |
0 |
處置/重估固定資產 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
稅率(%) |
14.61 |
13.97 |
14.52 |
14.56 |
14.71 |
12.96 |
13.98 |
14.18 |
28.76 |
11.53 |
3.46 |
9.63 |
10.18 |
7.44 |
0.82 |
3.56 |
0.0 |
營業額增長(%) |
13.16 |
11.93 |
17.88 |
39.99 |
11.97 |
-5.05 |
12.15 |
14.4 |
25.05 |
15.99 |
29.16 |
31.09 |
24.04 |
38.28 |
39.16 |
38.06 |
39.76 |
股東應占溢利增長(%) |
7.57 |
12.8 |
25.6 |
-14.79 |
56.31 |
-0.61 |
2.56 |
179.64 |
-61.06 |
-71.22 |
333.27 |
26.06 |
31.4 |
56.55 |
80.29 |
68.89 |
53.59 |
核數師意見 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
說明:1代表無保留意見;2代表保留意見;3代表修改意見
|
|